Tonix Pharmaceuticals Enrolls First Participant in the “RECOVERY” Study - a New Phase 3 Trial of Tonmya® for the Treatment of Posttraumatic Stress Disorder

Tonix Pharmaceuticals Enrolls First Participant in the “RECOVERY” Study — a New Phase 3 Trial of Tonmya® for the Treatment of Posttraumatic Stress Disorder

March 11, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search